F2G Ltd Announces $60 Million Financing to Progress Development of Novel Antifungal Agents June 20, 2016 by Brace Pharma Capital
Brace will be attending the Redefining Early Stage Investments (RESI) Conference June 23, 2016 May 24, 2016 by Brace Pharma Capital
Brace will be attending the Jefferies 2016 Healthcare Conference June 7-10, 2016 May 9, 2016 by Brace Pharma Capital
Brace will be attending the World Orphan Drug Congress April 20-22 March 23, 2016 by Brace Pharma Capital
Brace will be attending the RESI Houston Conference on April 11 March 23, 2016 by Brace Pharma Capital
Brace will be attending Cowen and Company\’s 36th Annual Healthcare Conference March 7- 9, 2016 March 3, 2016 by Brace Pharma Capital
Zymeworks Announces $61.5 Million Financing to Support the Clinical Development of its Pipeline January 8, 2016 by Brace Pharma Capital
Navitor Pharmaceuticals Announces $33 Million Series B Financing December 18, 2015 by Brace Pharma Capital
Brace will be attending the BIO CEO & Investor Forum in New York December 16, 2015 by Brace Pharma Capital
Brace will be attending the Cell & Gene Therapy Forum 2016 in Washington DC December 15, 2015 by Brace Pharma Capital
Brace will be attending the JP Morgan Healthcare Conference 2016 in San Francisco November 24, 2015 by Brace Pharma Capital
Brace will be attending the Biotech Showcase 2016 conference in San Francisco November 24, 2015 by Brace Pharma Capital
Brace will be attending the RESI Conference in San Francisco November 24, 2015 by Brace Pharma Capital
miRagen Therapeutics Secures $41 million Series C Financing to Advance Two MicroRNA Programs into Clinical Trials November 12, 2015 by Brace Pharma Capital
Therabron Therapeutics Receives Accelerated Second Tranche from Series B Financing and Expands Investor Syndicate November 12, 2015 by Brace Pharma Capital
Brace will be attending the Piper Jaffray Healthcare Conference in New York October 16, 2015 by Brace Pharma Capital
Brace will be attending the Jefferies Global Healthcare Conference October 6, 2015 by Brace Pharma Capital
Brace will be attending the World Orphan Drug Congress Europe 2015 October 6, 2015 by Brace Pharma Capital
ReViral announces US$21 million fundraising to advance clinical development of a novel anti-viral drug September 9, 2015 by Brace Pharma Capital
Brace will be attending Life Science Nation\’s RESI Conference in Boston August 26, 2015 by Brace Pharma Capital
Brace will be attending the 17th Annual Rodman & Renshaw Global Investment Conference August 24, 2015 by Brace Pharma Capital
Brace will be attending the Stem Cells Regenerative Medicine Congress 2015 August 24, 2015 by Brace Pharma Capital
Raymond Schinazi, Drug-development Pioneer, Earns VA\’s Highest Honor for Biomedical Research August 20, 2015 by Brace Pharma Capital
Brace will be attending the 14th Annual BIO Investor Forum in San Francisco July 8, 2015 by Brace Pharma Capital
Unum Therapeutics Announces $65 Million Series B Financing Round June 16, 2015 by Brace Pharma Capital
Brace will be Attending the Jefferies 2015 Healthcare Conference April 29, 2015 by Brace Pharma Capital
